BEAM vs CB · rev $63.5M vs P/E 14, rev $59.40B
Beam Therapeutics Inc (BEAM) versus Chubb Ltd (CB) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
BEAM currently screens at market cap $2.01B. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Not investment advice. Open the BEAM and CB stock pages for the full models.
Not investment advice.